NSF award 2555020 · University of Utah

GOALI: Cooperative Homogeneous-Heterogeneous Catalysis for Hydrogen Isotope Labeling of Pharmaceuticals

Final report due

30 March 2030

in 1,259 days · The award ends on 30 November 2029.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

Decide about an extension2 Aug 2029in 1019 days
award ending 2029-11-30 · Research.gov
This one is ours, not NSF’s.
Extension request16 Oct 2029in 1094 days
award ending 2029-11-30 · Research.gov
PAPPG 24-1: “at least 45 days prior to the end date”
No-cost extension notice20 Nov 2029in 1129 days
award ending 2029-11-30 · Research.gov
PAPPG 24-1: “at least ten calendar days prior to the end date”
Final report due30 Mar 2030in 1259 days
award ending 2029-11-30 · Research.gov
PAPPG 24-1: “no later than 120-days following the end date of the award”
Project outcomes report due30 Mar 2030in 1259 days
award ending 2029-11-30 · Research.gov
PAPPG 24-1: “no later than 120 days following the end date”
Award is closed out30 Mar 2030in 1259 days
award ending 2029-11-30 · Research.gov
PAPPG 24-1: “financially closed out 120 days after their expiration date”

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

NSF lists this award's end date as 30 November 2029.
NSF rules say the final report is due no later than 120 days after that.
So the final report is due by 30 March 2030.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number: 2555020
Period of support: 1 Dec 2026 – 30 Nov 2029
Amount: $562,468
Awardee: University of Utah, Salt Lake City, UT
Program: Chemical Catalysis
Directorate: MPS

Abstract

In this project, Professor Long Luo of the Department of Chemistry at the University of Utah is developing new ways to place special forms of hydrogen, known as deuterium and tritium isotopes, into pharmaceutical molecules. Compounds containing these isotopes are essential tools for tracking how medicines move through the body, measuring how drugs break down, and improving the safety and effectiveness of future…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.